Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Health coverage during and after COVID: 6 fallouts to watch for

As analyzed by the Kaiser Family Foundation, the outlook for job-based insurance under some post-COVID scenarios is unsurprisingly bleak.

Thumbnail

When patients can safely resume exercising after a COVID-19 diagnosis

As COVID-19 patients begin to bounce back, they are sure to have plenty of important questions about the recovery process. 

Thumbnail

COVID-19 especially harmful for heart transplant recipients

Heart transplant (HT) recipients have an increased risk of experiencing severe complications if infected with COVID-19, according to new findings published in JAMA Cardiology.

Thumbnail

FDA clears Philips imaging solutions for management of cardiac, lung complications related to COVID-19

Royal Philips announced Wednesday, May 13, that its ultrasound imaging solutions have been cleared by the FDA for the management of cardiac and lung complications associated with COVID-19.

Thumbnail

Hospitals in the mix as House Democrats pitch another $3T in COVID relief

A $3 trillion coronavirus relief bill proposed by House Democrats May 12 would allocate around $100 billion for hospitals and other healthcare providers to cover costs related to the public-health crisis.

Thumbnail

Rheumatoid arthritis associated with greater risk of HF, especially when CRP levels are high

Rheumatoid arthritis is associated with a greater risk of heart failure, according to new findings published in the Journal of the American Heart Association. The risk increases even more when patients have higher levels of C-reactive protein, a telltale sign of severe inflammation.  

Thumbnail

Mavacamten shows potential for treating hypertrophic cardiomyopathy in EXPLORER-HCM trial

Mavacamten has demonstrated value as a treatment option for patients with obstructive hypertrophic cardiomyopathy (HCM), according to results from the EXPLORER-HCM phase III clinical trial.

Thumbnail

5 notable quotes on COVID’s culling of 1.4 million healthcare jobs in April

Here’s a sampling of some of the best thinking on this body blow to the U.S. healthcare economy.